Safety and tolerability of colesevelam HCl in patients with T2DM

被引：0
|
作者：
Schwartz, Sherwyn L.
Zieve, Franklin
Kalin, Marcia
Jones, Michael R.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A480 / A480
页数：1
相关论文
共 50 条
  • [21] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Yan, Xueyu
    Si, Jinglei
    Zhong, Fangjie
    Wu, Yanjun
    Jiang, Qinyang
    Guo, Yafen
    Yang, Xiurong
    Liang, Jing
    Lan, Ganqiu
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 236 - 244
  • [22] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Xueyu Yan
    Jinglei Si
    Fangjie Zhong
    Yanjun Wu
    Qinyang Jiang
    Yafen Guo
    Xiurong Yang
    Jing Liang
    Ganqiu Lan
    [J]. International Journal of Diabetes in Developing Countries, 2022, 42 : 236 - 244
  • [23] Tolerability, Safety, Pharmacokinetics, and Therapeutic Efficacy of Once-Weekly Administration of GLP-1 Analogue in T2DM Patients
    Liu, Edy
    Guo, Xiaohui
    Tracey, Gregory
    Willett, Michael
    Lasseter, Kenneth
    Huang, Gavin
    Lv, Wei
    Zhou, Joe
    Zhang, Lihong
    Xu, Michael M.
    [J]. DIABETES, 2016, 65 : A268 - A268
  • [24] T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
    Thummasorn, Savitree
    Apichai, Sopida
    Chupradit, Supat
    Sirisattayawong, Pornpen
    Chaiwong, Pachpilai
    Sriwichaiin, Sirawit
    Pratchayasakul, Wasana
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    [J]. PLOS ONE, 2022, 17 (08):
  • [25] Efficacy and Safety of Sitagliptin in Hispanic Subjects with T2DM
    Raji, Annaswamy
    Long, Jianmin
    O'Neill, Edward A.
    Engel, Samuel S.
    [J]. DIABETES, 2017, 66 : A322 - A322
  • [26] Efficacy and Tolerability of Exenatide Twice Daily in Asian vs. White Patients With T2DM
    Sheu, Wayne H. H.
    Huang, Wenying
    Brunell, Steven C.
    Blase, Erich
    Horng, Mark
    Chen, Steve
    [J]. DIABETES, 2013, 62 : A266 - A267
  • [27] Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Subjects with T1DM and T2DM
    Morrow, Linda
    Grimm, Michael
    Beysen, Carine
    Walford, Geoffrey
    Duncan, Kelly
    Mitra, Pranab K.
    Vaddady, Pavan
    Hompesch, Marcus
    [J]. DIABETES, 2020, 69
  • [28] A placebo controlled single ascending dose Phase 1 for safety, tolerability, pharmacokinetics and pharmacodynamics of VRS-859 in patients with T2DM
    Cleland, J. L.
    Shore, C. R.
    Kipnes, M. S.
    [J]. DIABETOLOGIA, 2011, 54 : S318 - S318
  • [29] Safety and Tolerability of Combinations of Empagliflozin/Linagliptin (EMPA/LINA) for 52 Weeks in Subjects with Type 2 Diabetes (T2DM)
    Patel, Sanjay
    Defronzo, Ralph A.
    Lewin, Andrew
    Liu, Dacheng
    Kaste, Renee
    Kohler, Sven
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2015, 64 : A326 - A327
  • [30] Tolerability, Safety, PK/PD of Once-Weekly Administration of GLP-1 Analogue in T2DM Patients in China and US
    Liu, Ying
    Lv, Yuan
    Guo, Xiaohui
    Zhao, Caiyun
    Zhang, Junqing
    Wei, Minji
    Tracey, Gregory J.
    Lasseter, Kenneth C.
    Xu, Michael
    [J]. DIABETES, 2017, 66 : A296 - A296
12345